Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Dexmedetomidine as Adjuvant to Bupivacaine in Rhinoplasty
NCT07380139Phase 1Enrolling by invitation
- Sponsor
- Ain Shams University
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1 trial of dexamethasone and dexmedetomidine in postoperative pain (3 arms), sponsored by Ain Shams University. Primary endpoint: Time to the first request of analgesia at 9 months. Started Feb 2026; status: enrolling by invitation.
02
Drugs
dexamethasonedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07380139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07380139.